Cargando…
Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198844/ https://www.ncbi.nlm.nih.gov/pubmed/32371949 http://dx.doi.org/10.1038/s41392-020-0163-5 |
| _version_ | 1783529070328283136 |
|---|---|
| author | Li, Dongze Chen, You Liu, Hong Jia, Yu Li, Fanghui Wang, Wei Wu, Jiang Wan, Zhi Cao, Yu Zeng, Rui |
| author_facet | Li, Dongze Chen, You Liu, Hong Jia, Yu Li, Fanghui Wang, Wei Wu, Jiang Wan, Zhi Cao, Yu Zeng, Rui |
| author_sort | Li, Dongze |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7198844 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71988442020-05-05 Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study Li, Dongze Chen, You Liu, Hong Jia, Yu Li, Fanghui Wang, Wei Wu, Jiang Wan, Zhi Cao, Yu Zeng, Rui Signal Transduct Target Ther Letter Nature Publishing Group UK 2020-05-05 /pmc/articles/PMC7198844/ /pubmed/32371949 http://dx.doi.org/10.1038/s41392-020-0163-5 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Li, Dongze Chen, You Liu, Hong Jia, Yu Li, Fanghui Wang, Wei Wu, Jiang Wan, Zhi Cao, Yu Zeng, Rui Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study |
| title | Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study |
| title_full | Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study |
| title_fullStr | Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study |
| title_full_unstemmed | Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study |
| title_short | Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study |
| title_sort | immune dysfunction leads to mortality and organ injury in patients with covid-19 in china: insights from ers-covid-19 study |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198844/ https://www.ncbi.nlm.nih.gov/pubmed/32371949 http://dx.doi.org/10.1038/s41392-020-0163-5 |
| work_keys_str_mv | AT lidongze immunedysfunctionleadstomortalityandorganinjuryinpatientswithcovid19inchinainsightsfromerscovid19study AT chenyou immunedysfunctionleadstomortalityandorganinjuryinpatientswithcovid19inchinainsightsfromerscovid19study AT liuhong immunedysfunctionleadstomortalityandorganinjuryinpatientswithcovid19inchinainsightsfromerscovid19study AT jiayu immunedysfunctionleadstomortalityandorganinjuryinpatientswithcovid19inchinainsightsfromerscovid19study AT lifanghui immunedysfunctionleadstomortalityandorganinjuryinpatientswithcovid19inchinainsightsfromerscovid19study AT wangwei immunedysfunctionleadstomortalityandorganinjuryinpatientswithcovid19inchinainsightsfromerscovid19study AT wujiang immunedysfunctionleadstomortalityandorganinjuryinpatientswithcovid19inchinainsightsfromerscovid19study AT wanzhi immunedysfunctionleadstomortalityandorganinjuryinpatientswithcovid19inchinainsightsfromerscovid19study AT caoyu immunedysfunctionleadstomortalityandorganinjuryinpatientswithcovid19inchinainsightsfromerscovid19study AT zengrui immunedysfunctionleadstomortalityandorganinjuryinpatientswithcovid19inchinainsightsfromerscovid19study |